SenesTech (NASDAQ:SNES) Research Coverage Started at StockNews.com

Equities research analysts at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNESGet Free Report) in a research note issued on Monday. The brokerage set a “sell” rating on the stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $3.50 price objective on shares of SenesTech in a research note on Tuesday, May 14th.

Read Our Latest Research Report on SenesTech

SenesTech Stock Performance

SenesTech stock opened at $0.69 on Monday. The company has a quick ratio of 5.69, a current ratio of 6.91 and a debt-to-equity ratio of 0.03. SenesTech has a twelve month low of $0.52 and a twelve month high of $16.56. The stock’s fifty day simple moving average is $0.74 and its 200-day simple moving average is $0.88.

SenesTech (NASDAQ:SNESGet Free Report) last announced its quarterly earnings data on Thursday, May 9th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.02). The company had revenue of $0.42 million during the quarter, compared to analyst estimates of $0.43 million. SenesTech had a negative net margin of 545.82% and a negative return on equity of 181.46%. During the same quarter in the previous year, the business posted ($15.85) earnings per share. On average, analysts expect that SenesTech will post -1.1 EPS for the current year.

Institutional Trading of SenesTech

An institutional investor recently bought a new position in SenesTech stock. McAdam LLC purchased a new stake in SenesTech, Inc. (NASDAQ:SNESFree Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned approximately 1.25% of SenesTech at the end of the most recent reporting period. 5.19% of the stock is owned by institutional investors.

SenesTech Company Profile

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

See Also

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.